Determinants of steady-state mycophenolate mofetil pharmacokinetics in lupus patients

被引：0
|
作者：
Djabarouti, S.
Legeron, R. [1 ]
Saux, M. -C. [1 ]
Breilh, D. [1 ]
机构：
[1] Pharm Hop Haut Leveque, Clin Pharmacokinet EA2968, Pessac, France
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2011年 / 33卷 / 02期
关键词：
mycophenolic acid; pharmacokinetics; systemic lupus erythematosus;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：318 / 319
页数：2
相关论文
共 50 条
  • [1] Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
    Sarah Djabarouti
    Dominique Breilh
    Pierre Duffau
    Estibaliz Lazaro
    Carine Greib
    Olivier Caubet
    Marie-Claude Saux
    Jean-Luc Pellegrin
    Jean-François Viallard
    Arthritis Research & Therapy, 12
  • [2] Mycophenolate mofetil pharmacokinetics enable prediction of lupus clinical flares
    Djabarouti, S.
    Legeron, R.
    Pellegrin, J-L.
    Viallard, J. -F.
    Saux, M. -C.
    Breilh, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 466 - 467
  • [3] Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
    Woillard, Jean-Baptiste
    Bader-Meunier, Brigitte
    Salomon, Remi
    Ranchin, Bruno
    Decramer, Stephane
    Fischbach, Michel
    Berard, Etienne
    Guigonis, Vincent
    Harambat, Jerome
    Dunand, Olivier
    Tenenbaum, Julie
    Marquet, Pierre
    Saint-Marcoux, Franck
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) : 867 - 876
  • [4] STEADY-STATE PHARMACOKINETICS OF DOPAMINE IN ADULT PATIENTS
    LECORRE, P
    MALLEDANT, Y
    TANGUY, M
    LEVERGE, R
    CRITICAL CARE MEDICINE, 1993, 21 (11) : 1652 - 1657
  • [5] Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Indian Patients With Lupus Nephritis
    Koloskoff, Kevin
    Panwar, Ritika
    Rathi, Manish
    Mathew, Sumith
    Sharma, Aman
    Marquet, Pierre
    Benito, Sylvain
    Woillard, Jean-Baptiste
    Pattanaik, Smita
    THERAPEUTIC DRUG MONITORING, 2024, 46 (05) : 567 - 574
  • [6] Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients
    Cerqueira, PM
    Cesarino, EJ
    Mateus, FH
    Mere, Y
    Santos, SRCJ
    Lanchote, VL
    CHIRALITY, 1999, 11 (07) : 591 - 597
  • [7] Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients
    Cheatham, S. Christian
    Kays, Michael B.
    Smith, David W.
    Wack, Matthew F.
    Sowinski, Kevin M.
    PHARMACOTHERAPY, 2008, 28 (06): : 691 - 698
  • [8] Mycophenolate mofetil for lupus nephritis
    Olech, Ewa
    Merrill, Joan T.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (03) : 313 - 319
  • [9] Pharmacokinetics of mycophenolate mofetil in juvenile patients with autoimmune diseases
    Nakaseko, Haruna
    Iwata, Naomi
    Yasuoka, Ryuhei
    Kohagura, Toaki
    Abe, Naoki
    Kawabe, Shinji
    Mori, Masaaki
    MODERN RHEUMATOLOGY, 2019, 29 (06) : 1002 - 1006
  • [10] Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    Shimamura, Sanae
    Ono, Kota
    Hiromura, Keiju
    Sada, Kenei
    Mori, Masaaki
    Takei, Syuji
    Kawaguchi, Yasushi
    Tamura, Naoto
    Takasaki, Yoshinari
    MODERN RHEUMATOLOGY, 2015, 25 (06) : 854 - 857
12345